Summary of content
According to GIR (Global Info Research), the global revenue of anti-AIDS drugs in terms of revenue will be approximately US$ million in 2023 and is expected to reach US$ million in 2030, with a CAGR of % from 2024 to 2030. At the same time, the global sales of anti-AIDS drugs in 2023 are about and are expected to reach in 2030. In 2023, the market size of China will be about one million US dollars, accounting for about % of the global market, while the North American and European markets will account for % and % respectively in the same period. In the next few years, China's CAGR will be %, while the United States and Europe will play a more important role in the Asia-Pacific region, in addition to China, the United States and Europe, Japan, South Korea, India and Southeast Asia will remain important markets that cannot be ignored.
The major manufacturers of anti-HIV drugs in the global market include GSK, Cipla, MSD, Gilead Sciences, and Frontier Biotechnologies, among others, with the top four global players accounting for approximately % of the global market share by revenue in 2023.
In terms of product type, prescription drugs hold a significant position, with a market share of % in terms of revenue in 2023 and an expected share of % in 2030. At the same time, in terms of application, the share of hospitals will be about % in 2030, and the CAGR will be about % in the next few years.
This paper studies the global market, sales volume, sales revenue of anti-AIDS drugs in major regions and major countries, and also focuses on the competitive situation of major manufacturers (brands) in the world, sales, price, revenue and market share of anti-AIDS drugs.
According to the historical situation in the past five years (2019-2023), the overall scale of global anti-AIDS drugs, the scale of major regions, the scale and share of major enterprises, the scale of major product classifications, and the scale of major downstream applications in the past few years are analyzed. The sizing analysis includes sales, price, revenue, and market share, among other things. In view of the development prospects of anti-AIDS drugs in the next few years, this paper predicts that by 2030, it mainly includes global and major regional sales and revenue forecasts, sales volume and revenue forecasts by category, and sales volume and revenue forecasts of major anti-AIDS drugs.
Based on different product types, anti-AIDS drugs are subdivided into:
prescription drug
over-the-counter drug
Depending on the application, this article focuses on the following areas:
hospital
pharmacy
This article focuses on the major players in the global anti-AIDS drug industry, including:
GSK
Mullet
MSD
Gilead Sciences
Frontier Biotechnologies
This article focuses on major regions and countries around the world, with a focus on:
North American Market (US, Canada, and Mexico)
European markets (Germany, France, the United Kingdom, Russia, Italy, and the rest of Europe)
Asia-Pacific market (China, Japan, Korea, India, Southeast Asia, Australia, etc.)
South American markets (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, UAE, Turkey, etc.)
Brief introduction of the chapter:
Chapter 1, definitions, statistical scope, product classification, application, etc., global overall size and outlook
Chapter 2, company profile, including the company's basic information, main business and main products, sales of anti-AIDS drugs, revenue, price, the latest developments of the company, etc
Chapter 3: Global Competitive Landscape Analysis, Key Companies in Anti-AIDS Drug Sales, Price, Revenue and Share
Chapter 4, Key Regional Sizes and Forecasts
Chapter 5, Breakdown by Product Type, Segmentation Size, and Forecast
Chapter 6, Segmentation by Application, Segmentation of Size and Forecast
Chapter 7, North America Regional Breakdown, Segmentation by Country, Product Type, and Application, Segmentation Size and Forecast
Chapter 8, Europe segmentation, by country, product type, and application, segmentation size, and forecast
Chapter 9, Asia-Pacific Segmentation, Segmentation by Region, Product Type, and Application, Segmentation Size, and Forecast
Chapter 10, South America Regional Segmentation, Segmentation by Region, Product Type, and Application, Segmentation Size, and Forecast
Chapter 11, Middle East & Africa Segmentation, Segmentation by Region, Product Type, and Application, Segmentation Size and Forecast
Chapter 12, Market dynamics, including drivers, restraints, and trends
Chapter 13, Industry Industry Chain Analysis
Chapter 14, Sales Channel Analysis
Chapter 15 Conclusions of the Report
Table of contents of the text
1 Statistical Scope
1.1 Introduction to anti-AIDS drugs
1.2 Classification of anti-AIDS drugs
1.2.1 COMPARISON OF THE SCALE OF ANTI-HIV DRUGS BY PRODUCT TYPE IN THE GLOBAL MARKET: 2019 VS 2023 VS 2030
1.2.2 Prescription Drugs
1.2.3 Over-the-counter medications
1.3 Analysis of the main downstream markets for global anti-AIDS drugs
1.3.1 GLOBAL ANTI-HIV DRUGS MAJOR DOWNSTREAM MARKET SIZE COMPARISON: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Pharmacies
1.4 Overall size and forecast of the global anti-AIDS drug market
1.4.1 GLOBAL ANTI-HIVS DRUGS MARKET SIZE AND FORECAST: 2019 VS 2023 VS 2030
1.4.2 Global Market Sales of Anti-AIDS Drugs (2019-2030)
1.4.3 Price trends of anti-AIDS drugs in the global market
1.5 Global market capacity analysis of anti-AIDS drugs
1.5.1 Total production capacity of anti-HIV drugs in global market (2019-2030)
1.5.2 Global Market Anti-AIDS Drug Capacity Analysis by Key Regions
2 Company Profile
2.1 GSK
2.1.1 GSK Basic Information
2.1.2 GSK's main business and main products
2.1.3 GSK anti-AIDS drug product introduction
2.1.4 GSK Anti-AIDS Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Recent developments in GSK
2.2 Mullet
2.2.1 Basic information of CIPLA
2.2.2 Cipla's main business and main products
2.2.3 Cipla Anti-AIDS Drug Product Introduction
2.2.4 CIPLA Anti-AIDS Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CIPLA Latest Developments
2.3 MSD
2.3.1 MSD Basic Information
2.3.2 MSD's main business and main products
2.3.3 MSD anti-AIDS drug product introduction
2.3.4 MSD Anti-AIDS Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 MSD Latest Developments
2.4 Gilead Sciences
2.4.1 Gilead Sciences基本情况
2.4.2 Gilead Sciences' main business and main products
2.4.3 Gilead Sciences Anti-AIDS Drug Product Introduction
2.4.4 Gilead Sciences Anti-AIDS Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Gilead Sciences最新发展动态
2.5 Frontier Biotechnologies
2.5.1 Frontier Biotechnologies基本情况
2.5.2 Frontier Biotechnologies' main business and main products
2.5.3 Frontier Biotechnologies 抗艾滋病药物产品介绍
2.5.4 Frontier Biotechnologies Anti-AIDS Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Frontier Biotechnologies最新发展动态
3 Competitive landscape of major manufacturers of anti-HIV drugs in the global market
3.1 Global Anti-AIDS Drug Sales by Key Manufacturers (2019-2024)
3.2 Global Anti-AIDS Drug Revenue by Key Manufacturers (2019-2024)
3.3 Global Market Position of Major Manufacturers of Anti-HIV Drugs
3.4 Analysis of the concentration of the global anti-AIDS drug market
3.5 Product layout and regional distribution of major manufacturers of global anti-AIDS drugs
3.5.1 Regional distribution of major manufacturers of global anti-HIV drugs
3.5.2 Global Major Manufacturers of Anti-HIV Drug Product Types
3.5.3 Global Major Manufacturers of Anti-AIDS Drugs-related Business/Product Layout
3.5.4 Downstream markets and applications of global major manufacturers of anti-HIV drug products
3.6 New entrants to anti-HIV drugs and plans to expand production
3.7 Expansion of production and mergers and acquisitions in the anti-AIDS drug industry
4 Global major regional scale analysis
4.1 Global Anti-AIDS Drug Market Size by Major Regions
4.1.1 Global Sales of Anti-AIDS Drugs by Major Regions (2019-2030)
4.1.2 Global Anti-AIDS Drug Revenue by Major Regions (2019-2030)
4.2 North America Market Anti-AIDS Drug Revenue (2019-2030)
4.3 Europe Market Revenue of Anti-AIDS Drugs (2019-2030)
4.4 Asia-Pacific Market Revenue of Anti-AIDS Drugs (2019-2030)
4.5 South America Market Revenue of Anti-AIDS Drugs (2019-2030)
4.6 Middle East & Africa Market Revenue of Anti-AIDS Drugs (2019-2030)
5 Global Market: Market size of anti-AIDS drugs by product type
5.1 Global Sales of Anti-AIDS Drugs by Product Type (2019-2030)
5.2 Global Revenue of Anti-AIDS Drugs by Product Type (2019-2030)
5.3 Global Anti-HIV Drug Prices by Product Type, 2019-2030
6 Global Market Anti-AIDS Drugs Market Size by Application
6.1 Global sales volume of anti-HIV drugs by application (2019-2030)
6.2 Global Revenue from Anti-AIDS Drugs by Application (2019-2030)
6.3 Global Anti-AIDS Drug Prices by Application (2019-2030)
7 North America
7.1 North America Sales Volume of Anti-AIDS Drugs by Product Type (2019-2030)
7.2 North America Sales of Anti-AIDS Drugs by Application (2019-2030)
7.3 North America Anti-AIDS Drugs Market Size by Major Countries
7.3.1 North America Sales of Anti-AIDS Drugs by Major Countries (2019-2030)
7.3.2 North America Revenue from Anti-AIDS Drugs by Major Countries (2019-2030)
7.3.3 US Anti-AIDS Drug Market Size and Forecast (2019-2030)
7.3.4 Canada Anti-AIDS Drugs Market Size and Forecast (2019-2030)
7.3.5 Mexico Anti-AIDS Drugs Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Sales Volume of Anti-AIDS Drugs by Product Type (2019-2030)
8.2 Europe Sales of Anti-AIDS Drugs by Application (2019-2030)
8.3 Anti-AIDS Drug Market Size by Major European Countries
8.3.1 Sales of anti-AIDS drugs by major European countries (2019-2030)
8.3.2 Revenue from Anti-AIDS Drugs by Major European Countries (2019-2030)
8.3.3 Germany Anti-AIDS Drugs Market Size and Forecast 2019-2030
8.3.4 France Anti-AIDS Drugs Market Size and Forecast (2019-2030)
8.3.5 UK Anti-AIDS Drugs Market Size and Forecast 2019-2030
8.3.6 Russia Anti-AIDS Drugs Market Size and Forecast (2019-2030)
8.3.7 Italy Anti-AIDS Drugs Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Sales of Anti-AIDS Drugs by Product Type (2019-2030)
9.2 Asia-Pacific Sales of Anti-AIDS Drugs by Application (2019-2030)
9.3 Asia-Pacific Anti-AIDS Drugs Market Size by Major Regions
9.3.1 Sales of Anti-AIDS Drugs in Key Asia-Pacific Regions (2019-2030)
9.3.2 Revenue of Anti-AIDS Drugs by Major Asia-Pacific Regions (2019-2030)
9.3.3 China Anti-AIDS Drug Market Size and Forecast (2019-2030)
9.3.4 Japan Anti-AIDS Drugs Market Size and Forecast (2019-2030)
9.3.5 South Korea Anti-HIV Drug Market Size and Forecast (2019-2030)
9.3.6 India Anti-AIDS Drugs Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Anti-AIDS Drugs Market Size and Forecast (2019-2030)
9.3.8 Australia Anti-AIDS Drugs Market Size and Forecast 2019-2030
10 South America
10.1 South America Sales Volume of Anti-AIDS Drugs by Product Type (2019-2030)
10.2 South America Sales Volume of Anti-AIDS Drugs by Application (2019-2030)
10.3 South America Anti-AIDS Drug Market Size by Major Countries
10.3.1 Sales of Anti-AIDS Drugs by Major Countries in South America (2019-2030)
10.3.2 Revenue from Anti-AIDS Drugs by Major Countries in South America (2019-2030)
10.3.3 Brazil Anti-AIDS Drugs Market Size and Forecast (2019-2030)
10.3.4 Argentina Anti-AIDS Drugs Market Size and Forecast (2019-2030)
11 Middle East and Africa
11.1 Sales of Anti-AIDS Drugs by Product Type in Middle East and Africa (2019-2030)
11.2 Sales of Anti-AIDS Drugs by Application in Middle East & Africa (2019-2030)
11.3 Market Size of Anti-AIDS Drugs in Major Countries in Middle East and Africa
11.3.1 Sales of anti-AIDS drugs by major countries in Middle East and Africa (2019-2030)
11.3.2 Middle East & Africa Revenue from HIV/AIDS Drugs by Major Countries (2019-2030)
11.3.3 Turkey Anti-AIDS Drugs Market Size and Forecast (2019-2030)
11.3.4 Saudi Arabia Anti-AIDS Drug Market Size and Forecast (2019-2030)
11.3.5 UAE Anti-AIDS Drugs Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Anti-AIDS Drugs Market Drivers
12.2 Market Restraints for Anti-AIDS Drugs
12.3 Development Trends of the Anti-AIDS Drug Market
12.4 Analysis of Porter's Five Forces Model in the Anti-AIDS Drug Industry
12.4.1 The current competitiveness of competitors in the industry
12.4.2 Ability of potential competitors to enter
12.4.3 Bargaining Power of Suppliers
12.4.4 Bargaining Power of the Purchaser
12.4.5 Substitution capacity of substitutes
13 Industry chain analysis
13.1 Main raw materials and suppliers of anti-AIDS drugs
13.2 Cost structure and proportion of anti-AIDS drugs
13.3 Production process of anti-AIDS drugs
13.4 Anti-AIDS drug industry chain
14 Analysis of anti-AIDS drug sales channels
14.1 Distribution channels for anti-AIDS drugs
14.1.1 Direct Marketing
14.1.2 Distribution
14.2 Typical distributors of anti-AIDS drugs
14.3 Typical customers of anti-AIDS drugs
15 Conclusions
16 Appendix
16.1 Research Methodology
16.2 Research Process and Data Sources
16.3 Disclaimer of Warranties
Table of Contents of Charts
Table 1. Global Market Revenue of Anti-AIDS Drugs by Product Type, in USD Million, 2019 VS 2023 VS 2030
Table 2. Global Anti-AIDS Drug Revenue by Application (USD Million) & (2019 VS 2023 VS 2030)
Table 3. GSK's basic facts, origins and competitors
Table 4. GSK's main business and main products
Table 5. GSK Anti-AIDS Drug Product Introduction
Table 6. GSK Anti-AIDS Drug Sales Volume (10,000 Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. The latest developments from GSK
Table 8. Cipla Basics, Origins and Competitors
Table 9. Cipla's main business and main products
Table 10. Cipla Anti-AIDS Drug Product Introduction
Table 11. CIPLA Anti-AIDS Drug Sales (10,000 Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. The latest developments in Cipla
Table 13. MSD Basics, Origins and Competitors
Table 14. MSD's main business and main products
Table 15. MSD Anti-AIDS Drug Product Introduction
Table 16. MSD Anti-AIDS Drug Sales Volume (10,000 Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. The latest developments in MSD
Table 18. Basic information, origin and competitors of Gilead Sciences
Table 19. Gilead Sciences' main business and main products
Table 20. Gilead Sciences Anti-AIDS Drug Product Introduction
Table 21. Gilead Sciences Anti-AIDS Drug Sales Volume (10,000 Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. The latest developments in Gilead Sciences
Table 23. Frontier Biotechnologies Facts, Origins and Competitors
Table 24. Frontier Biotechnologies' main business and main products
Table 25. Frontier Biotechnologies Anti-AIDS Drug Product Introduction
Table 26. Frontier Biotechnologies Anti-AIDS Drug Sales Volume (10,000 Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
表 27. Frontier Biotechnologies最新发展动态
Table 28. Global Anti-AIDS Drug Sales by Major Manufacturers, 2019-2024 & (10,000 Doses)
Table 29. Global Anti-HIV Drug Sales Share by Major Manufacturers, 2019-2024
Table 30. Global Anti-HIV Drug Revenue by Key Manufacturers, 2019-2024 & (USD Million)
Table 31. Global Anti-HIV Drug Market Share by Major Manufacturers (2019-2024)
Table 32. Global Market Position of Key Manufacturers of Anti-HIV Drugs (Band 1, Band 2 and Band 3)
Table 33. Headquarters and production areas of major manufacturers of anti-AIDS drugs in the global market
Table 34. Types of anti-HIV drugs by major global manufacturers
Table 35. The business/product layout of major global manufacturers related to anti-AIDS drugs
Table 36. Downstream markets and applications of anti-HIV drug products of major global manufacturers
Table 37. New entrants to anti-HIV drugs and plans to expand production
Table 38. Expansion and mergers and acquisitions in the anti-AIDS drug industry
Table 39. Global Sales of Anti-AIDS Drugs by Major Regions, 2019-2024 & (10,000 doses)
Table 40. Global Sales of Anti-AIDS Drugs by Major Regions, 2025-2030 & (10,000 doses)
Table 41. Global Revenue Comparison of Anti-AIDS Drugs by Key Regions, 2019 VS 2023 VS 2030 & (USD Million)
Table 42. Global Anti-AIDS Drug Revenue by Key Regions, 2019-2024 & (USD Million)
Table 43. Global Anti-AIDS Drug Revenue by Key Regions, 2025-2030 & (USD Million)
Table 44. Global sales of anti-AIDS drugs by product type (2019-2024) & (10,000 doses)
Table 45. Global sales of anti-AIDS drugs by product type (2025-2030) & (10,000 doses)
Table 46. Global Anti-AIDS Drug Revenue by Product Type, 2019-2024 & (USD Million)
Table 47. Global Anti-HIV Drug Revenue by Product Type, 2025-2030 & (USD Million)
Table 48. Global Anti-AIDS Drug Prices by Product Type, 2019-2024 & (USD/dose)
Table 49. Global Anti-AIDS Drug Prices by Product Type, 2025-2030 & (USD/dose)
Table 50. Global sales of anti-AIDS drugs by application (2019-2024) & (10,000 doses)
Table 51. Global sales of anti-AIDS drugs by application, 2025-2030 & (10,000 doses)
Table 52. Global Anti-AIDS Drug Revenue by Application (2019-2024) & (USD Million)
Table 53. Global Anti-AIDS Drug Revenue by Application (2025-2030) & (USD Million)
Table 54. Global Anti-HIV Drug Price by Application (2019-2024) & (USD/dose)
Table 55. Global Anti-AIDS Drug Prices by Application (2025-2030) & (USD/dose)
Table 56. North America Sales of Anti-AIDS Drugs by Product Type, 2019-2024 & (10,000 doses)
Table 57. North America Sales of Anti-AIDS Drugs by Product Type, 2025-2030 & (10,000 doses)
Table 58. North America Sales of Anti-AIDS Drugs by Application (2019-2024) & (10,000 doses)
Table 59. North America Sales of Anti-AIDS Drugs by Application (2025-2030) & (10,000 doses)
Table 60. North America Sales of Anti-AIDS Drugs by Major Countries (2019-2024) & (10,000 Doses)
Table 61. Sales of Anti-AIDS Drugs in Major Countries in North America, 2025-2030 & (10,000 Doses)
Table 62. North America Anti-AIDS Drug Revenue by Major Countries, 2019-2024 & (USD Million)
Table 63. North America Anti-AIDS Drug Revenue by Major Countries, 2025-2030 & (USD Million)
Table 64. Sales of Anti-AIDS Drugs by Product Type in Europe (2019-2024) & (10,000 doses)
Table 65. Sales of Anti-AIDS Drugs by Product Type in Europe, 2025-2030 & (10,000 doses)
Table 66. Europe Sales of Anti-AIDS Drugs by Application (2019-2024) & (10,000 doses)
Table 67. Sales of anti-AIDS drugs by application in Europe, 2025-2030 & (10,000 doses)
Table 68. Sales of Anti-AIDS Drugs by Major European Countries (2019-2024) & (10,000 doses)
Table 69. Sales of Anti-AIDS Drugs in Major European Countries (2025-2030) & (10,000 doses)
Table 70. Revenue of Anti-AIDS Drugs by Major Countries in Europe, 2019-2024 & (USD Million)
Table 71. Revenue of Anti-AIDS Drugs by Major Countries in Europe, 2025-2030 & (USD Million)
Table 72. Sales volume of anti-AIDS drugs by product type in Asia-Pacific (2019-2024) & (10,000 doses)
Table 73. Sales volume of anti-AIDS drugs by product type in Asia-Pacific (2025-2030) & (10,000 doses)
Table 74. Sales volume of anti-AIDS drugs by application in Asia-Pacific (2019-2024) & (10,000 doses)
Table 75. Asia-Pacific Sales of Anti-AIDS Drugs by Application (2025-2030) & (10,000 doses)
Table 76. Sales of Anti-AIDS Drugs in Key Asia-Pacific Regions, 2019-2024 & (10,000 doses)
Table 77. Sales of Anti-AIDS Drugs in Key Asia-Pacific Regions, 2025-2030 & (10,000 doses)
Table 78. Asia-Pacific Key Regional Anti-AIDS Drug Revenue, 2019-2024 & (USD Million)
Table 79. Asia-Pacific Key Regional Anti-AIDS Drug Revenue (2025-2030) & (USD Million)
Table 80. Sales volume of anti-AIDS drugs by product type in South America, 2019-2024 & (10,000 doses)
Table 81. Sales of Anti-AIDS Drugs by Product Type in South America (2025-2030) & (10,000 doses)
Table 82. Sales volume of anti-AIDS drugs by application in South America (2019-2024) & (10,000 doses)
Table 83. South America Sales of Anti-AIDS Drugs by Application (2025-2030) & (10,000 doses)
Table 84. Sales of Anti-AIDS Drugs by Major Countries in South America, 2019-2024 & (10,000 Doses)
Table 85. Sales of Anti-AIDS Drugs by Major Countries in South America, 2025-2030 & (10,000 doses)
Table 86. South America's Anti-AIDS Drug Revenue by Major Countries, 2019-2024 & (USD Million)
Table 87. South America's Revenue from Anti-AIDS Drugs by Major Countries, 2025-2030 & (USD Million)
Table 88. Sales of Anti-AIDS Drugs by Product Type in Middle East & Africa, 2019-2024 & (10,000 doses)
Table 89. Sales of Anti-AIDS Drugs by Product Type in Middle East & Africa, 2025-2030 & (10,000 doses)
Table 90. Sales volume of anti-AIDS drugs by application in Middle East & Africa, 2019-2024 & (10,000 doses)
Table 91. Sales of Anti-AIDS Drugs by Application in Middle East & Africa, 2025-2030 & (10 000 doses)
Table 92. Sales of Anti-AIDS Drugs by Major Countries in Middle East & Africa (2019-2024) & (10,000 doses)
Table 93. Sales of Anti-AIDS Drugs by Major Countries in Middle East & Africa (2025-2030) & (10,000 doses)
Table 94. Middle East & Africa Revenue from HIV Drugs by Major Countries, 2019-2024 & (USD Million)
Table 95. Middle East & Africa Anti-AIDS Drug Revenue by Major Countries, 2025-2030 & (USD Million)
Table 96. The main raw material of anti-AIDS drugs
Table 97. Representative supplier of raw materials for anti-AIDS drugs
Table 98. Typical distributor of anti-AIDS drugs
Table 99. Typical customers of anti-AIDS drugs
Table of Contents of Charts
Figure 1. Anti-AIDS drug product images
Figure 2. Global Market Revenue of Anti-AIDS Drugs by Product Type, in USD Million, 2019 VS 2023 VS 2030
Figure 3. prescription drug
Figure 4. over-the-counter drug
Figure 5. Global Anti-HIV Drug Revenue by Application (USD Million) & 2019 VS 2023 VS 2030
Figure 6. hospital
Figure 7. pharmacy
Figure 8. Global revenue from anti-AIDS drugs (million dollars) & (10,000 doses): 2019 VS 2023 VS 2030
Figure 9. Global Anti-AIDS Drug Revenue and Forecast, 2019-2030 > (USD Million)
Figure 10. Global Market Sales of Anti-AIDS Drugs (2019-2030) & (10,000 doses)
Figure 11. Global Market Price Trends for Anti-AIDS Drugs, 2019-2030
Figure 12. Total Anti-HIV Drug Capacity in Global Market (2019-2030) & (10,000 doses)
Figure 13. Global Market Productivity Analysis of Anti-HIV Drugs by Key Regions: 2023 VS 2030
Figure 14. Global Tier 1, Tier 2 and Tier 3 Anti-HIV Drug Manufacturers Market Share (2023)
Figure 15. Global Top 3 Anti-HIV Drug Market Shares, 2023
Figure 16. Global Top 5 Anti-HIV Drug Market Shares, 2023
Figure 17. Global Anti-AIDS Drug Sales Share by Key Regions, 2019-2030
Figure 18. Global Anti-AIDS Drug Revenue Share by Key Regions, 2019-2030
Figure 19. North America Anti-AIDS Drug Revenue (2019-2030) & (USD Million)
Figure 20. Europe Market Anti-AIDS Drug Revenue, 2019-2030 & (USD Million)
Figure 21. Asia-Pacific Anti-HIV Drug Revenue (2019-2030) & (USD Million)
Figure 22. South America Anti-AIDS Drug Revenue, 2019-2030 & (USD Million)
Figure 23. Middle East & Africa Anti-AIDS Drug Revenue, 2019-2030 & (USD Million)
Figure 24. Global Anti-AIDS Drug Sales Share by Product Type, 2019-2030
Figure 25. Global Revenue Share of Anti-AIDS Drugs by Product Type, 2019-2030
Figure 26. Global Anti-AIDS Drug Prices by Product Type, 2019-2030
Figure 27. Global Anti-AIDS Drug Sales Share by Application (2019-2030)
Figure 28. Global Anti-AIDS Drug Revenue Share by Application (2019-2030)
Figure 29. Global Anti-HIV Drug Prices by Application (2019-2030)
Figure 30. North America Anti-AIDS Drug Sales Share by Product Type, 2019-2030
Figure 31. North America Anti-AIDS Drug Sales Share by Application (2019-2030)
Figure 32. North America Anti-AIDS Drug Sales Share by Key Countries, 2019-2030
Figure 33. North America Anti-AIDS Drug Revenue Share by Major Countries, 2019-2030
Figure 34. U.S. Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 35. Canada's Anti-AIDS Drug Revenue and Growth Rate (2019-2030)& (USD Million)
Figure 36. Mexico's Anti-HIV Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 37. Europe Share of Anti-AIDS Drug Sales by Product Type, 2019-2030
Figure 38. Europe Share of Anti-AIDS Drug Sales by Application (2019-2030)
Figure 39. Sales Share of Anti-AIDS Drugs by Major European Countries (2019-2030)
Figure 40. Share of Anti-AIDS Drug Revenue by Major Countries in Europe, 2019-2030
Figure 41. Germany Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 42. France Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 43. UK Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 44. Russia's Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 45. Italy Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Sales Share of Anti-AIDS Drugs by Product Type, 2019-2030
Figure 47. Asia-Pacific Anti-AIDS Drug Sales Share by Application (2019-2030)
Figure 48. Asia-Pacific Key Regional Anti-AIDS Drug Sales Share (2019-2030)
Figure 49. Asia-Pacific Key Regional Revenue Share of Anti-AIDS Drugs, 2019-2030
Figure 50. China's Anti-AIDS Drug Revenue and Growth Rate (2019-2030)& (USD Million)
Figure 51. Japan's Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 52. South Korea's Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 53. India's Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 54. Southeast Asia's Anti-HIV Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 55. Australia Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 56. South America Share of Anti-AIDS Drug Sales by Product Type, 2019-2030
Figure 57. South America Anti-AIDS Drug Sales Share by Application (2019-2030)
Figure 58. South America Sales Share of Anti-AIDS Drugs by Major Countries, 2019-2030
Figure 59. Share of Anti-AIDS Drug Revenue by Major Countries in South America, 2019-2030
Figure 60. Brazil's Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 61. Argentina Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 62. Middle East & Africa Sales Share of Anti-AIDS Drugs by Product Type, 2019-2030
Figure 63. Middle East & Africa Share of Anti-AIDS Drug Sales by Application (2019-2030)
Figure 64. Middle East & Africa Key Regional Anti-AIDS Drug Sales Share (2019-2030)
Figure 65. Middle East & Africa Key Regions Share of Anti-AIDS Drug Revenue, 2019-2030
Figure 66. Turkey's Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 67. Saudi Arabia's Anti-AIDS Drug Revenue and Growth Rate (2019-2030)&(USD Million)
Figure 68. UAE Anti-AIDS Drug Revenue and Growth Rate (2019-2030) & (USD Million)
Figure 69. Anti-HIV drugs market drivers
Figure 70. Market Restraints for Anti-AIDS Drugs
Figure 71. Market trends for anti-AIDS drugs
Figure 72. Porter's Five Forces Model Analysis of the Anti-AIDS Drug Industry
Figure 73. Cost structure and proportion of anti-AIDS drugs in 2023
Figure 74. The production process of anti-AIDS drugs
Figure 75. Anti-AIDS drug industry chain
Figure 76. Anti-AIDS drug sales channels: direct sales and distribution channels
Figure 77. Research Methods:
Figure 78. Research process and data sources